Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Britton Jimenez joins the company from Catalent Pharma Solutions.
February 2, 2021
By: Charlie Sternberg
Metrics Contract Services, a full-service contract development and manufacturing organization (CDMO) in novel oral solid dose products, has appointed Britton Jimenez as vice president of business development. Jimenez is responsible for marketing and sales in an executive leadership capacity to support the growing demand for novel oral solid dosage (OSD) projects that require Metrics’ expertise following significant expansion investments in Greenville, NC. The company has seen particular growth in oncologic therapeutics, which continue to dominate the drug development pipeline. Jimenez and his team will also focus on expanding our portfolio of global commercial manufacturing opportunities within Metrics. Jimenez joins from Catalent Pharma Solutions, where he was global director of business development. He has extensive experience in leading global business development teams, strategic planning, operational planning and partnership development in the pharmaceutical, biotechnology and medical device industries. Jimenez will report to John Ross, president of Mayne Pharma US and Metrics Contract Services, who said, “Metrics has an exceptional suite of end-to-end services to offer its clients and a reputation for leading science and great customer service in novel OSD development and manufacturing. Britton’s remit will be to expand awareness and reach as well as guide future investments to ensure that Metrics remains at the forefront of the OSD CDMO space. “Over recent years, we have noticed a growing demand from clients looking to develop and manufacture more complex, often potent drug products. We have the capabilities and infrastructure to meet this need, and by adding experienced individuals like Britton to the team, we will ensure that we further expand our presence and reputation as a leading CDMO in this particular segment of the novel OSD market.” The appointment coincides with the company’s latest investment which will see the addition of 3,760 square feet of potent-capable production space as part of a $10 million investment. Metrics has spent over $100 million in the last five years on its Greenville, NC campus.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !